Luminal Exosome Loading via MARCKS Fusion Proteins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for loading exosomes with therapeutic payloads are inefficient and limited, particularly in achieving high and reproducible loading of therapeutic proteins, due to stochastic localization and low efficiency in existing techniques such as overexpression and electroporation.
Innovation Solution
The use of newly identified protein markers like MARCKS, MARCKSL1, and BASP1, and their fragments, to facilitate high-efficiency loading of therapeutic proteins into exosomes by conjugating fusion proteins that direct the cargo molecules into the exosome lumen without additional ex vivo manipulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional overexpression methods are used to load exosomes with therapeutic payloads, then the process is simple, but the loading efficiency is low due to stochastic localization
Solution Approach 1:
The patent uses exosome-enriched luminal proteins (MARCKS, MARCKSL1, BASP1) as intermediary molecules to mediate the loading of therapeutic payloads into exosomes. These proteins contain specific peptide sequences that act as docking sites, enabling efficient and specific cargo loading without complex ex vivo manipulation while dramatically improving loading efficiency compared to traditional overexpression methods
2Adaptability or versatility
If electroporation is used to load purified exosomes, then specific payloads can be loaded, but the efficiency is low and it is limited to small payloads like siRNAs
Solution Approach 1:
The invention employs luminal proteins with specific peptide sequences as mediators that facilitate the loading of diverse therapeutic payloads including proteins, peptides, and other macromolecules into exosomes. This intermediary approach overcomes the size limitations of electroporation while maintaining high efficiency and versatility for different payload types
Solution Approach 2:
The patent changes the fundamental parameter of payload delivery from physical methods (electroporation) to biochemical methods using protein-peptide interactions. This allows loading of larger therapeutic proteins and peptides that cannot be effectively delivered by electroporation, expanding the range of adaptable payloads
3Ease of operation
If stochastic localization is used for payload delivery to exosome processing centers, then the process requires no additional manipulation, but the loading efficiency is limited
Solution Approach 1:
The patent introduces specific local quality through peptide sequences within luminal proteins that create dedicated docking sites for cargo molecules. This localized recognition mechanism ensures precise and reproducible loading at specific locations within the exosome, dramatically improving manufacturing precision while maintaining operational simplicity through cellular processing
Data Source
AI summary
The present invention relates to methods of preparing a therapeutic exosome using proteins newly identified to be enriched in the lumen of exosomes. Specifically, the present invention provides methods of localizing a therapeutic peptide or protein in exosomes. The methods involve generation of lumen-engineered exosomes that include one or more of the exosome proteins at higher concentrations, a modification or a fragment of the exosome protein, or a fusion protein of the exosome protein and a therapeutic or a cargo protein.